This webinar teaches the basics of The Life Raft Group's new software, GIST CHAT, which will replace our patient ListServ.
Dr. Nikhil Guhagarkar discusses the dental and oral complications of drugs used in GIST treatment and treatment of these side effects.
Dr. Jason Sicklick of Moores Cancer Center at the University of California San Diego talks about the Phase II study of Temozolomide (TMZ) in advanced SDH-mutant/deficient GIST, a new study available to patients with SDH-deficient GIST.
Kathy Sarmiento presents, The A B C’s of Medicare: Everything you need to know. Kathy explains everything from medicare costs and eligibility, to finding the right path for you.
Blueprint Medicines hosted a webinar for the GIST patient and caregiver community about Avapritinib, an investigational medicine for people with advanced GIST.
Medicare 101: An Overview of the A, B, C, and Ds of Medicare The A B C’s of Medicare: Everything you need to know What is Medicare, am I eligible and how do I enroll? [...]
This webcast was originally recorded May 21, 2019. Follow this link for webcast with Hebrew Subtitles. Listen to the webcast - Hebrew subtitles Are you interested in optimizing your treatment? In [...]
Most GIST patients will see a surgeon at some point during their treatment. This webcast will address the issues surrounding the decision to have an operation and considers that surgical options depend on a number of factors such as tumor location, tumor size, tumor number, response to drug therapy, and risk of recurrence.
SPAEN (Sarcoma Patients EuroNet) Presents Webinar Webinar "Novel therapy options in GIST: What's on the horizon?" was presented by Dr. Jonathan Trent, Professor of Medicine, Associate Director, Clinical Research Director, Sarcoma Medical Research Program [...]
Presentación del Dr. Chris Corless, profesor de patología en la Universidad de Oregón. Habla desde experiencia como patólogo trabajando con los tumores del estroma gastrointestinal (GIST). Nos actualiza sobre diagnóstico, mutaciones, riesgos de recurrencia, [...]